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The effect of repeated exposure to an additive dose of 
long ultraviolet (UV A) radiation on the erythemogenic 
and therapeutic effects of middle ultraviolet (UVB) ir-
radiation was investigated in 8 patients with psoriasis. 
The surface of the backs of these patients was divided 
into 2 parts, 1 of which r eceived only UVB irradiation 4 
times a week and the other UV A + UVB. UVB was 
provided by Philips TL-12 lamps and UV A by glass-
filtered Philips TL-09 lamps. UV A was held constantly 
at 10 J /cm2 , where'as UVB was increased. The erythem-
ogenic effects of UV A + UVB and UVB alone were 
evaluated by 4 tests during the treatment to determine 
the minimal erythema dose (MED). Test I (at the start of 
the therapy) showed a photoaugmentative effect which 
was no longer apparent in test ill (third week). Test III 
showed a reversal of the ratios of the MEDs of the sites 
irradiated with UVA + UVB and UVB (MED A+B/MED 
B). This is ascribed to the marked pigmelltation which 
appeared after repeated irradiation with the UV A + 
UVB combination. 
Comparison showed for the improvement of the pso-
riasis no distinct differences between UV A + UVB irra-
diation and UVB alone, but the former had the cosmetic 
advantage of giving pleasing .tan. 
It has been known ' for many years that psoriasis often re-
sponds favourably to exposure to sunlight. In the past few years 
good results have been obtained with UYB irradiation from 
artificial light sources [1,2]. In a previous paper [3] we reported 
the results of UYB phototherapy in 15 selected patients with 
psoriasis. The criterion applied for selection was a history of 
repeated striking improvement of the psoriasis after sunbathing. 
In addition, 30 unselected patients were treated with UYB 
irradiation. In both the selected and unselected patients sug-
gestions were obtained of a relationship between the response 
of the psoriasis to sunbathing and the response of the psoriasis 
to UYB phototherapy. However, in' 5 out of 34 patients who 
responded well to sunlight, the psoriasis was not improved by 
UYB phototherapy [4]. The question arose whether the results 
of UYB phototherapy could be improved by the addition of 
UY A radiation. It \:las been suggested that psoriasis can essen-
tially be cleared by artificial UY A radiation alone, but the' 
dosage required is extremely high and the exposure times are 
therefor.e not suitable for application in practice [5]. 
Recently, Willis, Kligman, and Epstein [6] and Ying, Parrish, 
and Pathak [7] found that pre-irradiation of skin with UY A 
increases 'the erythemogenic effect of UYB, as shown by the 
lowering of the minimal erythemal dose. Willis, Kligman, and 
Epstein called this phenomenon photoaugmentation. However, 
Ying, Parrish, and Pathak postulated a linear additive effect of 
UY A to UYE. All of these authors concluded that the effect of 
UYA decreased the MED of UYE. In these studies [6,7] the 
subjects were not given a series of irradiations. Repeated ex-
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posure within the range required to produce .erythema of un-
involved skin is, however, used in the treatment of psoriasis 
vulgaris [2]. This led us to investigate the effect of repeated 
exposure to an additional UYA dose (10 J /cm2) on the erythem-
ogenic effect of UYB phototherapy in patients with psoriasis, 
as judged from the minimal erythema dose (MED). At the 
same time, the therapeutic response was evaluated during the 
treatment with UYB and combined UY A + UYB irradiation. 
MATERIALS AND METHODS 
Patients 
Eight patients (5 males and 3 females) with a longstanding general-
ized and stable psoriasis of the plaque type were included in this study. 
Their ages ranged from 19 to 54 yr (mean 29.4). UVB, unlike UVA, was 
applied to the whole body. In all patients the plaques were distributed 
fairly symmetrically over the skin and showed no marked differences in 
clinical appearance. 
Light Sources and Cabins 
Erythemogenic irradiation (UVB) was supplied by a panel fitted 
with twelve 122 cm P hilips TL-12 40 w fluorescent tubes and twelve 61 
cm 20 w tubes on 2 hinged upright frames. All la mps were mounted 
vertically, the smaller above the larger. The main frame carried 8 long 
and 8 small tubes; the smaller side frame was fitted with 4 of each type. 
The angle between the 2 frames was 135°. T he lamps emi t a continuous 
wavelength spectrum ranging from approximately 280 to 380 nm with 
a peak at 305 nm and a spectrum distribution of: <280 nm: 0.4%, 280-
320 nm: 62%, 320-400 nm: 32%, and >400 nm: 5.6%. We shall refer to 
this system as UVB mdiation, since wavelengths longer than 320 nm 
contribu te less t han 1% of the erythema- inducing energy of this source. 
The light in tensity was measured by the actinometrical method ac-
cording to Hatehard and Parker [8]. The irradiance was 3.1 mw/cm2 at 
a dist.ance of 50 cm fTom the panel and 1.5 mw/ cm" at 100 cm. 
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As longwave UV light source, use was made of a semicircular panel 
fitted with 13 vertically mounted Philips TL-09 fluorescent lamps, 120 
em, 40 w each, with a maximum output at 350 nm. In front of this panel 
a shield made of 3-mm thick window-glass was mounted to eliminate 
wavelengths below 329 nm. T he spectral distribution of this glass-
filtered light is 320-360 run: 67.3%, 360-380 nm: 27.5%, and 380-400 run: 
5.2%. Light intensity was measured with a B1ak-Ray ultraviolet meter, 
model No. J 221 (Ultraviolet Products Inc. San Gabriel, California). At 
20 cm (lamp-to-skin distance) from the middle of the panel, the light 
intensity was 5.5 mw/cm2. 
Treatment Schedule 
The backs of the 8 patients were assigned at random to 1 of 2 groups 
on the basis of a left-right paired schedule, for purposes of comparison. 
One side of the back was irradiated firs t with UV A and then with UVB 
(ca lled site A + B). The other side of the back received only UVB (site 
B). The UVA dose was 10 J /cm2 which was maintained throughout the 
treatment. This dose required an exposure time of approximately 30 
min. Patients were treated 4 times a week (on Monday, Tuesday, 
Thursday, and Friday) during the clearing phase of the treatment, 
which was terminated when the psoriasis lesions showed no further 
improvement (in this series after 5-7 weeks). As topical medication, use 
was made, throughout the study, of 2-4% salicylic ac id in white petro. 
latum to aid the therapeutic effect of ultraviolet radiation [2]. The 
patients were to ld to apply the lubricant to the psoriasis lesions in the 
evening and to remove it in the morning (by showering). 
Determination of the Minimal Erythema Dose (MED) 
Four ligh t tes ts were performed in the 1st, 2nd, 3rd, and 5th week of 
treatment to determine the MED value obtained with the TL-12 panel 
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(UVB) . Half of the back was irradiated with 10 J /cm~ UVA (pre-
irradiation), and immediately after that the MED was determined for 
site A + B and site B. 
Six small round fields (diameter: 15 mm), chosen symmetrically on 
both halves of the back and all situated 100 cm from the center of the 
panel, were exposed to 45,90,135,180,225, and 270 mJ/cm2 (irradiation 
time: 0.5 to 3 min). After 24 h, the reactions were read. The lowest dose 
which induced erythema was considered to be the minimal erythema 
dose (MEDl. 
In the first week the light test was performed 24 hr before the first 
therapeutic irradiation and the resu lts were evaluated at the fU'st 
irradiation. In the 2nd test, the results were read on the 6th irradiation 
day; in the 3rd test, reading was done on the 10th- 12th irradiation day; 
and in the 4th test, on the 18th irradiation day. Tests I-IV were 
performed on different parts of the normal skin of the back, without 
overlapping. 
Dosage 
The first therapeutic light dose was equal to the highest dose in the 
test series that did not produce visible erythema (i.e., the sub-MED). 
Each half of the back thus received a different sub/MED dose. This 
was done by covering the half which had received its dose and then 
continuing the irradiation of the other half. The UVB dose was in-
creased by at most 25% between sessions except after test III (in the 
3rd week) , when the dose for the A + B site was increased on average 
by 40% (range (15-60%). If an area became markedly red and sensitive, 
the next irradiation was omitted. 
At weekly intervals during the initial treatment, the 2 parts of the 
back were compared and the percent involvement was estimated rela-
tive to the original status of the lesions. The therapeutic effect was then 
graded- asfoliows: 0 = not significantly improved; + 1 = 25% improved; 
decrease in scaling and infiltration of the lesions; +2 = 50% improved, 
moderate decrease in scaling and infiltration of plaques; +3 = 80% 
improved; marked decrease of psoriasis (flattening of inftltration and 
slight or no scaling); +4 = 95% improved; only scattered minipapules 
remain within the plaque, otherwise the skin appears normal; +5 = 
100% improved; no clinical evidence of psoriasis. 
RESULTS 
For each test, Table I shows the MED of the half of the back 
treated with UVA + UVB (MED A + B) , the MED of the UVB 
site (MED B), and the ratios between them (MED A + B/ 
MED B) . In 2 of the patients (No.3 and 6) MED A + B 
equalled MED B in the fust test, but the test areas of site A 
+ B were more erythematous than the corresponding areas of 
site B. For test I the mean ratio of MED A + B to MED B is 
0.79, and the 95% confidence interval for the mean ratio ranges 
from 0.69 to 0.88. The mean ratio is significantly lower than 1. 
In tests III and IV, MED A + B was higher than MED B in all 
cases; here, the mean ratios in both tests were significantly 
greater than 1, 1.40 and 1.36 respectively. 
Table II shows the total UVB dose for all patients and both 
halves of the back. At the end of the initial therapy the A + B 
site had received on average 34.7 J/cm2 and the B site 22.0 J / 
cm2. 
Table II also shows the degree of improvement for the 2 sites 
separately. Site A + B showed a higher degree of clearing in 
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only 1 patient (No.8) i.e., a higher final grade. This patient 
represented the only case of failure of irradiation therapy at 
both sites. In the course of the initial treatment 2 other patients 
(No.2 and 5) also showed detectable differences but at the fmal 
assessment both sites, as in the remaining patients, received 
the same final grade. In patient No. 2 site B showed some 
advantage after the 11th irradiation, and patient No.5 showed 
marginally better improvement at site A + B after the 22th 
irradiation. At site A + B, pigmentation was induced within 
psoriatic lesions and this seemed to camouflage some lesions. 
On closer inspection, however, there was no other distinct 
difference between site A + B and site B in 7 out of 8 patients. 
In all of the patients pigmentation of the normal skin was 
stronger and more evenly distributed at site A + B than at site 
B; and site A + B thus gained some advantage from the tanning 
effect. 
DISCUSSION 
Our series (tests I-IV) shows a marked increase of the MED's 
on site B and site A + B. Blum [9], who as early as 1945 found 
a sharp rise of the MED in the course of repeated irradiations, 
ascribed this increase mainly to a thickening of the epidermis 
and only to a small extent to pigmentation. 
The results of test I indicate that pre-irradiation with UV A 
intensifies the effects of erythemogenic irradiation (UVB) . This 
phenomenon can be explained by photoaugmentation [6,10-12] 
or photoaddition (7,13,14). Recently, Kaidbey and Kligman [15J 
argued that photoaugmentation is limited to the erythemal 
component of t,he sunburn reaction; in their histological study 
they found that UV A did not enhance sunburn cell production. 
In all patients the MED A + B/ MED B ratio reversed at 
some time during the treatment (Table I and Figure). Under 
this reversal we understand the moment at which the MED A 
+ B becomes larger than the MED B. Rosario et al. [16] found 
that unlike UV A, UVB led to distinct changes in the epidermis, 
such as acanthosis and thickening of the stratum corneum. 
Kaidbey and Kligman [17] concluded that except for the con-
TABLE II. Results at the end of the clearing phase 
Patient No. of irradiations total UVB Improvement 
No. during the initial dose (J / cm2) grade phase (4 per week) (0 to +5) 
I" lIb I" lIb 
1 24 48.6 29.6 +4 +4 
2 24 41.9 23.5 +3 +3 
3 18 14.2 10.7 +5 +5 
4 21 23.3 18.6 +4 +4 
5 28 47.7 27.4 +3 +3 
6 23 34.1 23.1 +4 +4 
7 26 36.7 26.4 +5 +5 
8 24 31.1 1604 +1 0 
mean 23.5 34.7 22.0 
"Site A + B (pre-irradiated with 10 J /cm2 UVA). 
b Site B (not pre-irradiated). 
TABLE I. MED values (280-380 nm) determined during UVA + UVB and UVB irradiation (in mJ/ cm z) 
test I (lst week) test II (2nd week) test III (3rd week) test IV (5th week) 
Patient No. 
MEDA+ U MEDu Ratio MEDA+ U MED" Ratio MEDA+u MEDu Ratio MEDA+ U MEDu Ratio 
1 180 225 0.80 360 450 0.80 900 540 1.67 3600 2880 1.25 
2 180 225 0.80 450 450 1.00 1080 720 1.50 3600 2340 1.54 
3 225 225 1.00 360 360 1.00 1800 1440 1.25 3240 2520 1.29 
4 180 270 0.67 b 1440 1080 1.33 4680 3600 1.30 
5 270 315 0.86 8'10 450 1.80 3060 2160 1.42 
6 360 360 1.00 720 720 1.00 2160 1800 1.20 3600 2880 1.25 
7 225 270 0.83 450 720 0.63 1080 900 1.20 2880 2160 1.33 
8 45 135 0.33 900 720 1.25 4320 2820 1.53 
Mean ratio 0.79 0.89 lAO 1.36 
SEM" 0.08 0.07 0.08 0.04 
" SEM = standard error of the mean. 
b 
- = not performed. 
58 BOER, SCHOTHORST, AND SUURMOND 
Ratio 
. 2 
a 
II HI IV Test no. 
Med A + B/ MED B ratio for each patient (No. 1-8) determined in 
4 tests (I-IV). Test II was not performed in patients 4, 5, and 8 (6, 'i/, 
0 ). The MED was determined for both sites (A + B and B) with the 
TL-12 panel (UVB). 
siderable increase in pigment granules, the epidermis and der-
mis of the UV A irradiated site were unchanged. Moreover, they 
found that for deep tans induced on the backs of volunteers by 
repeated UV A irradiation, the MED had to be 2 to 3 times 
higher to produce redness in the UV A-tanned skin. Up to the 
third test, site B received more UVB than site A + B or the 
same amount (patients 3 and 6) . Therefore, the changes as-
sumed to occur in the epidemis due to UVB in our study cannot 
explain the sharp rise of the MED A + B relative to the MED 
B. This effect might be explained by increased pigmentation 
caused by UV A. The extent to which the photoaugmentative 
effect is still present in tests III and IV is unknown. 
Stern and Kihiczak [18] found a beneficial effect on psoriasis 
plaques of combined UV A and UVB in a .proportion mimicking 
summer sunlight; UVB alone induced no clinical response. 
Under our aggressive UVB irradiation there was hardly any 
difference between the two sites with respect to improvement 
of the psoriasis lesions throughout the treatment, but there was 
some cosmetic advantage for site A + B due to the attractive 
tan. 
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The absence of marked differences in improvement of pso-
riasis might be explained by the relatively high UVB component 
(maximally at the end of the treatment) in the UV radiation to 
which the A + B site was exposed. It would be of interest to 
fmd out whether a constant balanced UV A: UVB ratio (as for 
example, in solar radiation) is essential to obtain better results 
in psoriasis. 
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